다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Kintara Therapeutics Inc (KTRA)
Kintara Therapeutics Inc (KTRA) 뉴스

KTRA

Kintara Therapeutics (KTRA)

Kintara Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KTRA

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/18	05:10	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/18	05:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/15	05:55	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/15	05:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/15	05:45	PR Newswire (US)	Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/15	05:40	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/05/14	05:06	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/04/06	02:09	PR Newswire (US)	Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/04/03	20:00	PR Newswire (US)	Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/03/27	22:00	PR Newswire (US)	Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/27	20:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/26	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/22	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/15	06:07	PR Newswire (US)	Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/12	23:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2024/02/12	23:00	PR Newswire (US)	Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/19	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/19	06:05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/16	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/07	23:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/07	23:00	PR Newswire (US)	Kintara Therapeutics Announces Review of Strategic Alternatives	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/05	23:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/12/05	23:00	PR Newswire (US)	Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/11/21	21:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/11/14	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/11/14	06:10	PR Newswire (US)	Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/11/14	06:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/10/31	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/10/31	21:00	PR Newswire (US)	Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study	NASDAQ:KTRA	Kintara Therapeutics Inc
2023/10/28	05:05	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:KTRA	Kintara Therapeutics Inc

검색 관련기사 보기:NASDAQ:KTRA

1 2 3 4 5 6 7 다음 >>

PIMCO Flexible Emerging ...

Bridgeline Digital

Amundi Ftse Epra Europe ...

Nishimatsuya Chain (PK)

Oryx International Growth

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관